Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph Corey

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Future Microbiology|March 10, 2010
Telavancin's interactions with the bacterial cell membraneEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
Diagnostic Microbiology and Infectious Disease|January 14, 2015
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USAMartin E Stryjewski, Ronald N Jones, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Reply to DiNubileG Ralph Corey, Helen W Boucher, Martin E Stryjewski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Introduction: fusidic acid enters the United StatesRobert C Moellering, G Ralph Corey, M Lindsay Grayson
International Journal of Antimicrobial Agents|November 26, 2009
Short-course therapy for bloodstream infections in immunocompetent adultsG Ralph Corey, Martin E Stryjewski, Richard J Everts
Expert Review of Anti-Infective Therapy|October 4, 2012
Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studiesEsteban C Nannini, G Ralph Corey, Martin E Stryjewski
The New England Journal of Medicine|March 7, 2008
Clinical problem-solving. A key miscommunication--an 81-year-old woman presented to the emergency department with increasing abdominal distention, nausea, and vomitingMelissa H Kong, G Ralph Corey, Thomas Bashore, et al.
Expert Opinion on Pharmacotherapy|November 15, 2011
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumoniaEthan Rubinstein, G Ralph Corey, Martin E Stryjewski, et al.
Diagnostic Microbiology and Infectious Disease|July 23, 2013
Diagnostic dilemma in a returning traveler with feverJelena Catania, Seth S Martin, G Ralph Corey, et al.
American Heart Journal|April 13, 2004
Novel approaches to clinical trials: device-related infectionsRobert M Califf, Vance Fowler, Christopher H Cabell, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Future Microbiology|March 10, 2010
Telavancin's interactions with the bacterial cell membraneEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
Diagnostic Microbiology and Infectious Disease|January 14, 2015
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USAMartin E Stryjewski, Ronald N Jones, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Reply to DiNubileG Ralph Corey, Helen W Boucher, Martin E Stryjewski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Introduction: fusidic acid enters the United StatesRobert C Moellering, G Ralph Corey, M Lindsay Grayson
International Journal of Antimicrobial Agents|November 26, 2009
Short-course therapy for bloodstream infections in immunocompetent adultsG Ralph Corey, Martin E Stryjewski, Richard J Everts
Expert Review of Anti-Infective Therapy|October 4, 2012
Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studiesEsteban C Nannini, G Ralph Corey, Martin E Stryjewski
The New England Journal of Medicine|March 7, 2008
Clinical problem-solving. A key miscommunication--an 81-year-old woman presented to the emergency department with increasing abdominal distention, nausea, and vomitingMelissa H Kong, G Ralph Corey, Thomas Bashore, et al.
Expert Opinion on Pharmacotherapy|November 15, 2011
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumoniaEthan Rubinstein, G Ralph Corey, Martin E Stryjewski, et al.
Diagnostic Microbiology and Infectious Disease|July 23, 2013
Diagnostic dilemma in a returning traveler with feverJelena Catania, Seth S Martin, G Ralph Corey, et al.
American Heart Journal|April 13, 2004
Novel approaches to clinical trials: device-related infectionsRobert M Califf, Vance Fowler, Christopher H Cabell, et al.
Pageof 16